Medical technology & services NanoViricides advances Phase 2 trials for broad-spectrum antiviral NV-378 in $17B market: analysts By Proactive 17/12/2025
Tech Inside Biotech: Telix, regulatory resets and the weight of unresolved risk By Proactive 17/12/2025
Food & drink Treasurey Wine Estates shares hit 11-year low on guidance “miss” By Proactive 17/12/2025
Mining Confidence in the Mining Industry soars in the second half of 2025 as critical and rare earth mineral deals signed with US By Proactive 16/12/2025
Tech Tech Bytes: DroneShield bucks the tech sell-off with $49.6m European military deal By Proactive 16/12/2025
Tech Sparc Al’s mathematical approach to location assessment a perfect fit for drones and more By Proactive 15/12/2025
Manufacturing & engineering SNDL earnings results validate cannabis and alcohol strategy By Proactive 15/12/2025
Pharma & Biotech ME Therapeutics on a mission to reprogram the human immune response to cancer By Proactive 15/12/2025
Pharma & Biotech Bright Minds Biosciences has standout year with epilepsy drug in Phase II trials By Proactive 15/12/2025
Tech HydroGraph Clean Power aims for wider graphene adoption with fresh approach to ultra-pure production By Proactive 15/12/2025
Pharma & Biotech Inside Biotech: When AI gives drug candidates a second analytical life By Proactive 15/12/2025
Investments and investor services Frank Talk: Copper rally is accelerating as AI data centers push global supply toward crisis levels By Proactive 12/12/2025
Retail & consumer Soft November jobs data likely to keep RBA's cash rate call on hold By Proactive 11/12/2025
Mining New Happy Creek Minerals CEO looking to turn high-grade Fox Tungsten deposit into a mine By Proactive 11/12/2025
Financial Services Russell 2000 hits record as small-cap optimism grows on rate-cut prospects By Proactive 10/12/2025
Health Inside Biotech: Epiminder’s IPO tests investor appetite for med-tech scale-up stories By Proactive 10/12/2025